Evidence map›Paper›PMID 42012257›Full record

ArticleJournal of proteome research2026

Parkinson's Disease-Associated Remodeling of Synaptic

Moyinoluwa Adeniyi, Mojibola Fowowe, Odunayo Oluokun, Sarah Sahioun, Vishal Sandilya, Oluwatosin Daramola, Andrew I Bennett, Yehia Mechref

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of proteome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Moyinoluwa AdeniyiDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409-1061, United States.
Mojibola FowoweDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409-1061, United States.
Odunayo OluokunDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409-1061, United States.
Sarah SahiounDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409-1061, United States.
Vishal SandilyaDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409-1061, United States.
Oluwatosin DaramolaDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409-1061, United States.
Andrew I BennettDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409-1061, United States.
Yehia MechrefDepartment of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas 79409-1061, United States.ORCID 0000-0002-6661-6073

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is characterized by progressive motor and cognitive dysfunction and is associated with synaptic pathology and impaired neurotransmission, including dysfunction of synaptic vesicles (SVs) and presynaptic terminals. However, the role of protein

Indexed as

Parkinson DiseasePolysaccharidesPrefrontal CortexSynapsesSynaptic VesiclesChromatography, LiquidFemaleGlycomicsGlycosylationHumansMaleSynaptosomesTandem Mass SpectrometryPolysaccharidesisomerLC-MS/MSN-glycanParkinson’s diseaseprefrontal cortexsynaptic vesiclesynaptosome

Identifiers

PMID42012257
PMCPMC13248020

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.